Cargando…

Efficacy and Safety of Direct Oral Anticoagulant for Treatment of Atrial Fibrillation in Cerebral Amyloid Angiopathy

A 75-year-old man with a history of atrial fibrillation (AF) and anticoagulant therapy presented with a headache. Cerebral amyloid angiopathy (CAA) was diagnosed after MRI of the brain revealed cortical superficial siderosis, lobar intracerebral hemorrhage, and lobar microbleeds. Anticoagulant thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Narita, Koichi, Amiya, Eisuke, Komuro, Issei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2020
Materias:	Cardiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7462646/ https://www.ncbi.nlm.nih.gov/pubmed/32884877 http://dx.doi.org/10.7759/cureus.10143

Ejemplares similares

The Effectiveness and Safety of Direct Oral Anticoagulants in Obese Patients With Atrial Fibrillation: A Network Meta-Analysis
por: Salah, Qais M, et al.
Publicado: (2023)

Obesity Paradox in Atrial Fibrillation and its Relation with the New Oral Anticoagulants
por: Filho, André Inocêncio Novaes Lima, et al.
Publicado: (2022)

Systematic Review and Meta-Analysis: Can We Compare Direct Oral Anticoagulants to Warfarin in Patients With Atrial Fibrillation and Bio-Prosthetic Valves?
por: Adhikari, Govinda, et al.
Publicado: (2021)

Stroke prevention in an octogenarian with atrial fibrillation, cerebral amyloid angiopathy and intracerebral hemorrhage
por: Stöllberger, Claudia, et al.
Publicado: (2023)

Comparison Between Oral Anticoagulation and Left Atrial Appendage Occlusion in the Prevention of Stroke With Regard to Non-Valvular Atrial Fibrillation
por: Sandhu, Osama, et al.
Publicado: (2020)

Novel Oral Anticoagulants in Patients With Atrial Fibrillation and Moderate to Severe Mitral Stenosis: A Systematic Review
por: Al Rawahi, Mohamed N, et al.
Publicado: (2023)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Early Versus Delayed Oral Anticoagulation in Patients With Acute Ischemic Stroke Due to Atrial Fibrillation: A Meta-Analysis
por: Tirumandyam, Gayathri, et al.
Publicado: (2023)

Acute Mesenteric Ischemia in a Chronically Anticoagulated Patient With Atrial Fibrillation: Anticoagulation Reversal, Management and Preventing Recurrence
por: Aziz, Ahmed Ali, et al.
Publicado: (2022)

Use of Anticoagulants in Patients With Non-Valvular Atrial Fibrillation Who Are at Risk of Falls
por: Shanah, Layla, et al.
Publicado: (2020)

Is percutaneous coronary intervention safe during uninterrupted direct oral anticoagulant therapy in patients with atrial fibrillation and acute coronary syndromes?
por: De Luca, Leonardo, et al.
Publicado: (2021)

Appearances of Premature Atrial and Ventricular Contractions After Switching From Brand Name to Generic Cibenzoline
por: Oguri, Gaku, et al.
Publicado: (2023)

Assessment of Awareness Levels About Anticoagulants in Patients With Atrial Fibrillation Presenting to Emergency Department
por: Akman, Canan, et al.
Publicado: (2021)

Gait in Cerebral Amyloid Angiopathy
por: Sharma, Breni, et al.
Publicado: (2022)

Cerebral amyloid angiopathy: an update
por: Schroeder, B. E., et al.
Publicado: (2023)

Cerebral amyloid angiopathy related inflammation: An under recognized but treatable complication of cerebral amyloid angiopathy
por: Berry-Noronha, Alexander, et al.
Publicado: (2023)

Recovery of sinus rhythm by tafamidis in patients with wild-type transthyretin amyloid cardiomyopathy with atrial arrhythmias
por: Isotani, Yoshitaka, et al.
Publicado: (2022)

Expert Opinion on the Use of Novel Oral Anticoagulants for Stroke Prevention in Non-valvular Atrial Fibrillation for the Primary Care Setting in India: A Literature Review
por: Dalal, Jamshed, et al.
Publicado: (2022)

Oral Anticoagulation in Patients With Atrial High-Rate Episodes: Focus on Clinical Implications
por: Dimou, Smaro, et al.
Publicado: (2023)

Uninterrupted Direct Oral Anticoagulants Without a Change in Regimen for Catheter Ablation for Atrial Fibrillation Is an Acceptable Protocol
por: Oshima, Tsukasa, et al.
Publicado: (2021)

Cardiac Tamponade Risk Associated With Anticoagulation for Atrial Fibrillation in Dialysis-Associated Pericarditis: A Case Report
por: Abu-Abaa, Mohammad, et al.
Publicado: (2023)

Cerebral Amyloid Angiopathy With a Hypomanic Episode Treated With Valproic Acid
por: Okamoto, Naomichi, et al.
Publicado: (2021)

Non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation in secondary stroke and systemic embolism prevention
por: Gorczyca, Iwona, et al.
Publicado: (2019)

Ischemic Stroke in a Patient With Atrial Tachycardia, Methylenetetrahydrofolate Reductase Mutation and New-Onset Atrial Fibrillation: Is Early Initiation of Anticoagulation Therapy Indicated?
por: Eyituoyo, Harry O, et al.
Publicado: (2020)

Diffuse Cerebral Air Emboli After an Esophagogastroduodenoscopy One Month Post Left Atrial Ablation for Atrial Fibrillation
por: Abu-Shaban, Kamil, et al.
Publicado: (2021)

Superficial siderosis in cerebral amyloid angiopathy
por: Wani, Nisar Ahmad, et al.
Publicado: (2011)

Cerebral Amyloid Angiopathy: Emerging Concepts
por: Yamada, Masahito
Publicado: (2015)

Advances in cerebral amyloid angiopathy imaging
por: Chen, Szu-Ju, et al.
Publicado: (2019)

Understanding the Pathophysiology of Cerebral Amyloid Angiopathy
por: Gatti, Laura, et al.
Publicado: (2020)

The Efficacy of Lactulose for the Treatment of Hyperammonemic Encephalopathy Due to Severe Heart Failure
por: Narita, Koichi, et al.
Publicado: (2020)

Anticoagulation for Stroke Prevention of Concomitant Atrial Fibrillation and End-Stage Renal Disease: Insights of Cardiologists and Nephrologists From India
por: ES, Swetha, et al.
Publicado: (2022)

A Challenging Case of a Patient With Immune Thrombocytopenic Purpura on Eltrombopag Who Developed Atrial Fibrillation: An Anticoagulation Dilemma
por: Yasin, Ahmed K, et al.
Publicado: (2023)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

Effectiveness and safety of self-managed oral anticoagulant therapy compared with direct oral anticoagulants in patients with atrial fibrillation
por: Grove, Erik Lerkevang, et al.
Publicado: (2018)

Influence of atrial fibrillation on oxygen uptake and exercise tolerance in cardiovascular patients; close association with heart rate response
por: Takano, Nami, et al.
Publicado: (2019)

Effectiveness and Safety of Direct Oral Anticoagulant for Secondary Prevention in Asians with Atrial Fibrillation
por: Park, Jiesuck, et al.
Publicado: (2019)

Safety and Efficacy of Direct Oral Anticoagulants for Atrial Fibrillation in Patients with Renal Impairment
por: Jang, Soo Min, et al.
Publicado: (2020)

Safety of direct oral anticoagulants compared to warfarin in cirrhotic patients with atrial fibrillation
por: Yoo, Seo Yeon, et al.
Publicado: (2022)

Managing antithrombotic treatment in a patient with atrial fibrillation and coronary stent with transient neurological symptoms in cerebral amyloid angiopathy
por: Ravn, Julie, et al.
Publicado: (2022)

The association of fracture risk in atrial fibrillation patients and long-term anticoagulant therapy category: a systematic review and meta-analysis
por: Chen, Jun, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_vib9gc2iboa71jruqhs6fdb2v6